Ranbaxy Launches Pravastatin Sodium Tablets in US

by VR Sreeraman on  June 25, 2007 at 8:34 PM Drug News
RSS Email Print This Page Comment
Ranbaxy Launches Pravastatin Sodium Tablets in US
Mumbai, June 25 (IANS) Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases.
Advertisement

Being the first-to-file, the company will enjoy a 180-day exclusivity for the pravastatin 80mg and benefit from the commercial gains during the period, it informed the Bombay Stock Exchange (BSE).

Advertisement
The annual sales for the tablets, used for prevention of several types coronary heart diseases, were $209 million, it said.

Source: IANS
LIN/S
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Hyponatremia 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive